Alveo is transforming point-of-care diagnostics with be.well—a low-cost, easy-to-use molecular testing platform. A co-winner of the XPRIZE Rapid COVID Testing, be.well delivers results in under an hour at the point of need via a portable analyzer, single-use multiplex cartridges, and a mobile app. Its patented direct electrical sensing of nucleic-acid amplification cuts cost and complexity, while cloud analytics enable real-time management and outbreak tracking.